Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

A gut-activated NHR-86–CYP pathway mediates the neuroprotective effects of Enterococcus faecium probiotics in a nematode model of amyotrophic lateral sclerosis

4 months ago 52

PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

  • Loading metrics

Open Access

Peer-reviewed

Research Article

?

This is an uncorrected proof.

Abstract

Neurodegenerative diseases are often associated with oxidative stress, and while probiotics may influence neuronal health, the underlying mechanisms remain poorly understood. Using the sod-1 A4VM amyotrophic lateral sclerosis (ALS) model in Caenorhabditis elegans, we investigated the protective effects of the probiotic Enterococcus faecium against oxidative stress-induced neurodegeneration. Animals fed E. faecium showed reduced motor neuron degeneration under oxidative stress compared to those maintained on a standard Escherichia coli diet. Transcriptome analysis revealed a significant enrichment of oxidoreductase genes, including cytochrome P450 (cyp) genes. RNAi-mediated knockdown of cyp genes impaired E. faecium-mediated neuroprotection, and this loss correlated with increased reactive oxygen species (ROS) levels. We identified the conserved nuclear hormone receptor NHR-86 as a key regulator of cyp gene expression and neuroprotection. Loss of nhr-86 abolished the probiotic’s protective benefits, while transgenic expression of nhr-86 restored cyp induction and neuronal resilience. Importantly, intestinal expression of NHR-86 was sufficient to restore CYP induction and neuronal resilience, whereas neuronal knockdown had no effect, indicating that gut NHR-86 activity is essential for this protective pathway. These findings reveal a previously uncharacterized NHR-CYP regulatory axis activated by an intestinal probiotic, highlighting a mechanistic link between microbial signals and host neuroprotection.

Citation: Sang Y, Ren J, Aballay A (2026) A gut-activated NHR-86–CYP pathway mediates the neuroprotective effects of Enterococcus faecium probiotics in a nematode model of amyotrophic lateral sclerosis. PLoS Biol 24(1): e3003627. https://doi.org/10.1371/journal.pbio.3003627

Academic Editor: Ursula Jakob, U of Michigan, UNITED STATES OF AMERICA

Received: May 28, 2025; Accepted: January 16, 2026; Published: January 30, 2026

Copyright: © 2026 Sang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the paper and its Supporting information files.

Funding: This work was fully supported by the National Institutes of Health (NIH) through grants GM0709077 awarded to AA and AI117911 awarded to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors received a salary from the funders for this work.

Competing interests: The authors have declared that no competing interests exist.

Abbreviations: ALS, amyotrophic lateral sclerosis; BHI, brain–heart infusion; DAVID, Database for Annotation, Visualization, and Integrated Discovery; GO, gene ontology; HNF4, hepatocyte nuclear factor 4; LB, Luria-Bertani; NGM, nematode growth medium; NHRs, nuclear hormone receptors; qRT-PCR, quantitative reverse transcription PCR; RNAi, RNA interference; ROS, reactive oxygen species

Introduction

Neurodegenerative diseases, including Alzheimer’s, Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis (ALS), progressively damage the nervous system, leading to severe physical and cognitive impairments. ALS, a fatal neurodegenerative disorder, is characterized by motor neuron degeneration, resulting in muscular atrophy, weakness, dysphagia, dysarthria, dyspnea, limb motor impairments, and eventual paralysis in the advanced stages. Respiratory failure and death usually occur within 2−3 years. Over 40 gene mutations have been linked to ALS [1]. Among these, the most common genetic cause is the chromosome 9 open reading frame 72 (C9orf72) hexanucleotide repeat expansion, followed by mutations in TAR DNA-binding protein and fused in sarcoma [2,3]. Mutations in SOD1 account for ~10%–20% of familial ALS and ~1%–2% of all ALS cases [4]. However, few clinical therapeutic or preventive strategies specifically target SOD-1 [5]. The SOD-1 A4V mutation is the most common SOD-1 mutation in the United States, accounting for about 50% of cases [6]. It is conserved in mammals, was the first identified SOD-1 mutation, and remains a primary cause of ALS among SOD-1-related cases. Here, we investigated the protective role of probiotics in preventing motor neuron degeneration using the sod-1 A4VM model, which carries a single copy of SOD-1 A4V mutation and exhibits heightened degeneration due to oxidative stress.

We used C. elegans as a powerful model organism for studying neurodegeneration due to its simple and well-characterized nervous system. Its transparent body and short life span allow for real-time observation of neuronal function and degeneration, making it ideal for investigating the mechanisms of neurodegenerative diseases [7]. The ability to introduce human disease mutations, such as those linked to ALS, further enhances its utility in modeling motor neuron degeneration [8].

Accumulating evidence suggests that probiotic bacteria play a vital role in human health and well-being by modulating key physiological processes [9,10]. Among these, probiotics have been shown to enhance resistance to oxidative stress, a major contributor to motor neuron degeneration [11,12]. Enterococci, particularly Enterococcus faecium, have been widely used as probiotics due to their beneficial effects on host health [13,14]. Our recent studies demonstrate that E. faecium effectively protects the host against a lethal Salmonella enterica infection by activating the Wnt pathway, a crucial regulator of cellular homeostasis [15]. These findings suggest that E. faecium may offer neuroprotective benefits in vivo, potentially mitigating neurodegenerative disorders caused by oxidative damage.

The cytochrome P450 (CYP) family plays a critical role in reducing free radicals and influencing neurodegenerative diseases. While some CYP enzymes contribute to oxidative stress, others detoxify reactive oxygen species (ROS), regulate lipid metabolism, and clear toxic metabolites, making them potential targets for neuroprotective therapies. Growing evidence links CYP expression patterns to brain activity and neurological function. For example, CYP46A1 has been identified as a therapeutic target in Alzheimer’s disease, suggesting its potential influence on disease progression [16,17]. In Parkinson’s disease, CYPs exhibit both protective and harmful effects, further highlighting the complexity of their roles [18,19]. Overall, CYP-mediated endogenous metabolism is closely connected to neurodegenerative diseases and plays a significant role in the central nervous system, influencing steroid synthesis, inflammation, and drug metabolism.

Nuclear hormone receptors (NHRs) are transcription factors that control essential biological processes upon binding specific exogenous or endogenous ligands. Overexpressing NHRs in the intestine can alleviate motor neuron degeneration, with NHRs mediating the protective effects of propionate against α-synuclein-induced neuronal death in a C. elegans model of Parkinson’s disease [20]. Moreover, recent studies have demonstrated that NHR activation modulates neuronal survival pathways and mitochondrial homeostasis, highlighting their potential as therapeutic targets for neurodegenerative diseases [21].

Utilizing a single-copy ALS SOD-1 knock-in model in C. elegans, we studied the protective role of E. faecium against motor neuron degeneration under oxidative stress. We found that exposure to E. faecium triggered a broad induction of cytochrome P450 genes. These CYPs contributed to E. faecium-mediated neuroprotection by reducing intracellular ROS levels during oxidative stress. We identified NHR-86, a conserved NHR and the homolog of human hepatocyte nuclear factor 4 (HNF4), as a key regulator of this response. NHR-86 protected against motor neuron degeneration by activating CYP genes in response to E. faecium. The intestinal function of NHR-86 is required for CYP induction and neuronal resilience, supporting an indirect role for intestinal oxidative stress mitigation in neuronal protection. Together, these findings reveal a novel neuroprotective mechanism involving CYP activation and suggest potential strategies for targeting neurodegenerative diseases.

Results

E. faecium protects C. elegans against motor neuron degeneration under oxidative stress

The SOD-1 A4V mutation is the most prevalent disease-associated SOD-1 allele among ALS patients in North America [6]. Patients carrying this mutation typically experience selective degeneration and death of cholinergic spinal motor neurons, while glutamatergic neurons remain functional. Similarly, in C. elegans, the sod-1 A4VM model exhibits cholinergic motor neuron loss under oxidative stress, with glutamatergic neurons unaffected. Moreover, single-copy sod-1 A4VM knock-in animals in sod-1(-) background show significantly greater susceptibility to oxidative stress compared to sod-1 WTM knock-in animals in the same genetic background [22], exhibiting an accelerated neurodegenerative phenotype, and providing a reliable model for detecting motor neuron degeneration. Under basal conditions, the single-copy SOD-1 A4VM model does not show cholinergic motor neuron loss or functional defects in young adult animals, indicating that neurodegeneration in this model is primarily stress-dependent [22]. Therefore, we selected the ALS sod-1 A4VM model to investigate the effects of probiotic E. faecium on the integrity of cholinergic motor neurons under oxidative stress, which was induced using paraquat [23]. Following paraquat exposure, some sod-1 A4VM animals displayed defects in cholinergic motor neurons (Figs 1A and S1). To test whether E. faecium protects C. elegans against cholinergic motor neuron degeneration under oxidative stress, animals were pretreated with E. faecium for 24 hours before being transferred to paraquat plates (Fig 1B). Escherichia coli, a bacterial food for laboratory maintenance of C. elegans, was used as a control. The cholinergic motor neuron integrity was studied using GFP retention/loss in animals carrying the unc-17p::GFP gene, which expresses fluorescent proteins in cholinergic neurons. Less than 10 % of sod-1 WTM animals showed motor neuron degeneration when pretreated with either E. coli or E. faecium, with no significant difference between the two treatments (Figs 1C, S1, and S2). Fifty percent of sod-1 A4VM animals showed motor neuron degeneration when pretreated with E. coli, while only 20 % of sod-1 A4VM animals pretreated with E. faecium showed motor neuron degeneration (Figs 1C and S2). Importantly, we found that both UV-killed and heat-killed E. faecium failed to provide neuroprotection (S3A and S3B Fig), indicating that live E. faecium is required for this protective effect.

thumbnail

Fig 1. Enterococcus faecium protects against motor neuron degeneration under oxidative stress in Caenorhabditis elegans.

(A) Representative images of the ALS sod-1 A4VM model show motor neuron degeneration in animals fed Escherichia coli followed by oxidative stress induced by 5 mM paraquat. Cholinergic motor neurons were visualized with unc-17p::GFP. After 24 hours of exposure, representative images of sod-1 A4VM animals were captured, showing those without (top) and with (bottom) neurodegeneration. Enlarged images in the right panels highlight motor neuron defects, indicated by red circles. (B) Schematic of the experimental design for probiotic E. faecium pretreatment and paraquat exposure. Young adult animals were pretreated on E. faecium or E. coli lawns for 24 hours, followed by a 24-hour exposure to paraquat. Figure created using BioRender. Sang, Y. (2026) https://BioRender.com/fg7i4lx. (C) Oxidative stress induced cholinergic motor neuron degeneration in sod-1 A4VM animals. Cholinergic motor neuron integrity was assessed using GFP retention or loss in sod-1 A4VM animals following probiotic E. faecium pretreatment and paraquat exposure. Cholinergic motor neuron integrity was accessed by scoring for the absence of at least two cholinergic motor neurons posterior to the vulva. (D) Survival curve showing E. faecium-mediated protection against paraquat-induced oxidative stress. Following 24 hours of paraquat exposure, the survival of sod-1 A4VM animals pretreated on E. faecium or E. coli lawns was recorded. Animals were transferred to new paraquat plates daily until all animals stopped laying eggs. (E) Locomotion of sod-1 A4VM animals following paraquat exposure. Each sod-1 A4VM animal was pretreated on an E. faecium or E. coli lawn, exposed to 5 mM paraquat for 48 hours, and allowed to move freely for 15 s. Locomotion was quantified using the movement index, calculated as the ratio of movement distance to body length. Columns of defective neurons, survival curves, and locomotion represent assays from three independent experiments (n = 15). Abbreviations: Ec, E. coli OP50; Ef, E. faecium; WT, wild-type. The data underlying this Figure can be found in S1 Data.

https://doi.org/10.1371/journal.pbio.3003627.g001

We also assessed whether E. faecium-mediated neuroprotection promotes survival during oxidative stress. Animals treated with E. faecium survived significantly better than those treated with E. coli (Fig 1D). Since E. faecium protects motor neurons against neurodegeneration, we investigated whether E. faecium treatment affects locomotion. Animals were pretreated with E. faecium followed by paraquat-induced oxidative stress. E. faecium rescued the oxidative stress-induced locomotion defect (Fig 1E). These results indicate that probiotic E. faecium preserves cholinergic motor neuron integrity and locomotor function under oxidative stress.

Because ALS patients with the SOD1 A4V mutation exhibit loss of glutamatergic neurons, we next examined whether E. faecium protects these neurons. Using a sod-1 G85RM model of glutamatergic neurodegeneration [22], we studied the sensory glutamatergic neurons PHA and PHB, which are susceptible to degeneration under paraquat-induced oxidative stress (S4A Fig). E. faecium treatment reduced degeneration in these neurons (S4B Fig), indicating that its neuroprotective effects extend beyond cholinergic motor neurons.

Classic immune pathways are not required in probiotic-mediated neuroprotection

To identify genes and pathways required in E. faecium-mediated neuroprotection, we performed transcriptome analysis comparing E. faecium-treated and E. coli-treated sod-1 A4VM animals. Of the 302 differentially regulated genes, 227 were up-regulated, and 75 were down-regulated upon exposure to E. faecium (S1 Table). To identify related gene groups directly or indirectly regulated by E. faecium exposure, we performed an unbiased gene enrichment analysis using the Database for Annotation, Visualization, and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov/) [24]. The top gene ontology (GO) clusters with the highest DAVID enrichment scores are shown in Fig 2A and 2B and S2 Table. For the down-regulated gene subset responding to E. faecium exposure, the most highly enriched clusters were related to innate immune response and transmembrane transport, followed by lipid transport, S-adenosylmethionine biosynthesis, and one-carbon metabolic process (Fig 2A). For the up-regulated gene set, the highest-scoring ontology clusters included oxidoreductase activity and hydrolase activity, followed by genes related to iron ion binding and structure constituent of the cuticle, among others (Fig 2B). As expected, a similar enrichment was also observed using a Wormbase enrichment analysis tool (https://wormbase.org/tools/enrichment/tea/tea.cgi) [25,26], which is specific for C. elegans gene data analysis. Innate immune response genes and oxidoreductase activity genes were also highly enriched among down-regulated and up-regulated genes, respectively (S5 Fig and S2 Table). Additionally, we compared our enrichment analysis with a similar study that examined gene expression differences between E. faecium and E. coli treated wild-type animals. We found comparable results, even though their comparison was between E. faecium and heat-killed E. coli (S2 Table) [27].

thumbnail

Fig 2. Gene signature upon Enterococcus faecium exposure.

(A) GO analysis of (A) down-regulated and (B) up-regulated genes in sod-1 WTM and sod-1 A4VM animals exposed to Escherichia coli or E. faecium. (B) qRT-PCR validation of the innate immune response genes that were down-regulated with E. faecium treatment (N = 3 biological replicates). (C) qRT-PCR validation of the oxidoreductase activity genes that were up-regulated with E. faecium treatment (N = 3 biological replicates). Values are expressed as the fold difference compared with sod-1 WTM animals fed on E. coli ± SD by one-way ANOVA with Tukey’s multiple comparisons test, * P < 0.05, ** P < 0.01, *** P < 0.001. The data underlying this Figure can be found in S1 Data.

https://doi.org/10.1371/journal.pbio.3003627.g002

We validated gene expression using qRT-PCR, selecting candidate genes from two key clusters: the innate immune response cluster (top down-regulated) and oxidoreductase activity cluster (top up-regulated). These genes were assessed under four conditions: sod-1 WTM and sod-1 A4VM animals exposed to either E. coli or E. faecium. Innate immune genes were consistently down-regulated in an E. faecium–dependent manner (Fig 2C), while oxidoreductase activity genes were up-regulated (Fig 2D). The qRT-PCR results confirmed the RNA-seq findings, demonstrating a positive correlation and reinforcing that E. faecium specifically drives these gene expression changes.

Since the innate immune response cluster was among the most strongly down-regulated by E. faecium exposure, we hypothesized that activation of canonical immune pathways may contribute to motor neuron degeneration and that their suppression could be protective. To test this, we used RNAi to knock down classic immune pathways, including PMK-1 [2830], DAF-16 [3133], ELT-2 [34,35], and SKN-1 [36,37], in animals subjected to paraquat-induced oxidative stress in the presence and absence of E. faecium (Fig 3A). Because RNAi by feeding is largely ineffective in most neurons, these experiments primarily reflect the roles of these genes in the intestine and other non-neuronal tissues. As shown in Figs 3B and S6, RNAi of pmk-1, daf-16, elt-2, or skn-1 did not prevent motor neuron degeneration in animals fed E. coli and did not alter the neuroprotective effect of E. faecium treatment, indicating that modulation of these canonical immune pathways is not a determining factor in neuroprotection under oxidative stress.

thumbnail

Fig 3. Enterococcus faecium-mediated neuroprotection in Caenorhabditis elegans does not require classic immune pathways.

(A) Schematic of RNAi-specific genes, pretreatment with probiotic E. faecium, and paraquat exposure. Gravid sod-1 A4VM animals laid eggs on RNAi and control plates. The eggs hatched and grew into young adults, which were then treated on E. faecium or Escherichia coli lawns for 24 hours before a 24-hour paraquat exposure. Figure created using BioRender. Sang, Y. (2026) https://BioRender.com/fg7i4lx. (B) Oxidative stress induced cholinergic motor neuron degeneration in sod-1 A4VM animals. sod-1 A4VM animals were fed control or pmk-1, elt-2, daf-16, and skn-1 RNAi. After growing to young adults on RNAi plates, the animals were treated with E. faecium or E. coli for 24 hours before a 24-hour paraquat exposure. Cholinergic motor neuron integrity was accessed by scoring for the absence of at least two cholinergic motor neurons posterior to the vulva. * P < 0.05, ** P < 0.01, *** P < 0.001. RNAi, RNA interference. The data underlying this Figure can be found in S1 Data.

https://doi.org/10.1371/journal.pbio.3003627.g003

Cytochrome P450 genes protect against motor neuron degeneration during oxidative stress

Our transcriptomic analysis of E. faecium-treated animals revealed a strong enrichment of oxidoreductase genes (Fig 2B), suggesting that these genes may play a role in neuroprotection. Notably, 10 out of the 23 genes in the oxidoreductase activity cluster belong to the cytochrome P450 (CYP) family (S2 Table), a group previously linked to neurodegenerative processes [17,38]. qRT-PCR analysis confirmed that multiple cyp genes, including cyp-35A3, cyp-35A1, cyp-35C1, cpy-33C8, cpy-34A9, cyp-35D1, cpy-13A7, cpy-33C9, cyp-35A5, and cyp-13A5, were up-regulated upon E. faecium exposure in sod-1 WTM and sod-1 A4VM animals (S7 Fig).

Some CYP enzymes contribute to ROS generation [39,40], while others help defense against oxidative stress [4143]. To test whether CYPs are required in E. faecium-mediated neuroprotection, we knocked down several cyp genes up-regulated by E. faecium. Due to sequence similarity and redundancy, cyp-35A12345 can be knocked down by mixed RNAi, which targets all five genes [44]. Knock down of cyp-35A12345 decreased E. faecium-mediated protection against motor neuron degeneration (Figs 4A and S8). We also detected the survival of animals and locomotion with cyp-35A12345 knockdown and found that inhibition of cyp-35A12345 also decreased animal survival (Fig 4B) and locomotion (Fig 4C) protection conferred by E. faecium exposure.

thumbnail

Fig 4. Cytochrome P450s are required in Enterococcus faecium-mediated neuroprotection.

(A) Oxidative stress induced cholinergic motor neuron degeneration in sod-1 A4VM animals. sod-1 A4VM animals were fed HT115 expressing control or cyp-35A12345 RNAi. After growing to young adults on RNAi plates, the animals were treated with E. faecium or Escherichia coli for 24 hours before a 24-hour paraquat exposure. Cholinergic motor neuron integrity was accessed by scoring for the absence of at least two cholinergic motor neurons posterior to the vulva. * P < 0.05, ** P < 0.01, *** P < 0.001. (B) Survival curve of cyp-35A12345 knockdown with E. faecium pretreatment, followed by paraquat-induced oxidative stress. sod-1 A4VM animals were fed HT115 expressing control or cyp-35A12345 RNAi and grown into young adults. After 24 hours of paraquat exposure, the survival rate of these animals, pretreated on E. faecium and E. coli lawns, was recorded. Animals were transferred to new paraquat plates daily until all animals stopped laying eggs. (C) Locomotion analysis of sod-1 A4VM animals after cyp-35A12345 knockdown, following E. faecium pretreatment and paraquat exposure. sod-1 A4VM animals were fed HT115 expressing control or cyp-35A12345 RNAi and grown into young adults. Each young adult was pretreated on E. faecium or E. coli lawn, then exposed to 5mM paraquat for 48 hours. The ratio of movement distance to body length, measured using NIH ImageJ software, was used as a movement index. (D) Intracellular ROS analysis of sod-1 A4VM animals after cyp-35A12345 knockdown, following E. faecium pretreatment and paraquat exposure. Intracellular ROS levels were shown in green. (E) Quantification of DCF fluorescence intensity in (D), n = 25. The “n” represents the number of animals in each experiment. N = 3 biological replicates. The data underlying this Figure can be found in S1 Data.

https://doi.org/10.1371/journal.pbio.3003627.g004

To explore the mechanism of CYP-mediated neuroprotection during oxidative stress, we measured intracellular ROS levels using the fluorescent probes 2′,7′-dichlorofluorescein diacetate (H2DCFDA) [45]. Animals fed on E. coli followed by paraquat treatment showed high ROS levels, while E. faecium-treated animals showed low ROS levels when exposed to paraquat. Knocking down cyp-35A12345 decreased the reduction of ROS levels conferred by E. faecium exposure (Fig 4D and 4E). Together, these results demonstrate that CYPs are required in E. faecium-mediated neuroprotection and function, at least in part, by reducing intracellular ROS levels during oxidative stress.

NHR-86 is required in E. faecium-mediated neuroprotection

CYP enzymes are central to xenobiotic metabolism and are tightly regulated by NHRs in mammals and C. elegans [4649]. In response to xenobiotic exposure, NHRs function as transcription factors that activate genes encoding metabolic enzymes and components of multi-drug efflux pumps [50]. To determine whether NHRs mediate E. faecium-induced expression of cyp genes, we first identified candidate nhr genes involved in this regulatory pathway.

A previous transcriptomic study found that both cyp and nhr genes were up-regulated in C. elegans exposed to genotoxic compounds, suggesting coordinated regulation of these gene families [48,51]. We performed a candidate mutant screen targeting 13 nhr genes responsible for regulating cyp genes (nhr-62, nhr-130, nhr-201, nhr-203, nhr-237, nhr-86, nhr-207, nhr-235, nhr-11, nhr-12, nhr-106, nhr-196, and nhr-205) using cyp-35A1, cyp-35A3, and cyp-35A5 as transcriptional readouts. Treatment with E. faecium in wild-type animals led to robust induction of cyp-35A1 expression. This induction was significantly reduced by RNAi targeting either nhr-203 or nhr-86 (Fig 5A), indicating that both nuclear receptors contribute to the regulation of cyp-35A1. In contrast, the expression of cyp-35A3 and cyp-35A5 in response to E. faecium depended solely on nhr-86, as their mRNA levels were unaffected by nhr-203 knockdown (S9 Fig).

thumbnail

Fig 5. NHR-86 is required for Enterococcus faecium-mediated neuroprotection.

(A) Screening of nhr genes using cyp-35A1 as a reporter. qRT-PCR analysis of cyp-35A1 mRNA levels in nhr mutants. Young adult nhr mutant animals pretreated on E. faecium or Escherichia coli lawns were harvested for RNA extraction and qRT-PCR assay. (N = 3 biological replicates). Values represent fold differences relative to animals fed on E. coli, analyzed by one-way ANOVA with Tukey’s multiple comparisons test, * P < 0.05, ** P < 0.01, *** P < 0.001. (B) Oxidative stress induced cholinergic motor neuron degeneration in sod-1 A4VM animals. sod-1 A4VM animals were fed HT115 expressing nhr-86, nhr-203 or empty vector as a control. After growing to young adults on RNAi plates, the animals were treated with E. faecium or E. coli for 24 hours before a 24-hour paraquat exposure. Cholinergic motor neuron integrity was accessed by scoring for the absence of at least two cholinergic motor neurons posterior to the vulva. * P < 0.05, ** P < 0.01, *** P < 0.001. RNAi, RNA interference. (C) Intracellular ROS analysis of sod-1 A4VM animals after nhr-86 or nhr-203 knockdown, following E. faecium pretreatment and paraquat exposure. Intracellular ROS levels were shown in green. (D) Dot-plot representation of green fluorescence intensity vs. TOF of vector or nhr-86 RNAi animals exposed to E. faecium or E. coli followed by paraquat exposure (n = 300). (E) Frequency distribution of green fluorescence in vector or nhr-86 RNAi animals exposed to E. faecium or E. coli followed by paraquat exposure. Three independent experiments were conducted. Empty vector, Ec-paraquat vs. Empty vector, Ef-paraquat, P < 0.0001; Empty vector, Ec-paraquat vs. nhr-86 RNAi, Ec-paraquat, P = 0.1240; Empty vector, Ef-paraquat vs. nhr-86 RNAi,Ef-paraquat, P < 0.0001; nhr-86 RNAi, Ec-paraquat vs. nhr-86 RNAi, Ef-paraquat, P < 0.0001. (F) Locomotion analysis of sod-1 A4VM animals after nhr-86 knockdown, following E. faecium pretreatment and paraquat exposure. sod-1 A4VM animals were fed HT115 expressing nhr-86 and grown to young adults. Each young adult was pretreated on E. faecium or E. coli lawn, then exposed to 5mM paraquat for 48 hours. The ratio of movement distance to body length, measured using NIH ImageJ software, was used as a movement index. (G) Survival curve of nhr-86 knockdown with E. faecium pretreatment, followed by paraquat-induced oxidative stress. sod-1 A4VM animals were fed HT115 expressing nhr-86 and grown to young adults. After 24 hours of paraquat exposure, the survival rate of these animals, pretreated on E. faecium and E. coli lawns, was recorded. Animals were transferred to new paraquat plates daily until all animals stopped laying eggs, and survival was scored. The data underlying this Figure can be found in S1 Data.

https://doi.org/10.1371/journal.pbio.3003627.g005

We next tested whether nhr-86 or nhr-203 was required on E. faecium-mediated neuroprotection. Knocking down nhr-86, but not nhr-203, impaired E. faecium-mediated protection against motor neuron degeneration (Figs 5B and S10) and reduced the suppression of ROS levels (Figs 5C and S11). These findings were further supported by large particle flow cytometry, which showed that E. faecium-induced reductions in intracellular ROS were dependent on nhr-86 (Fig 5D and 5E), but not on nhr-203 (S12 Fig). Additionally, nhr-86 knockdown abolished the protective effects of E. faecium on oxidative stress-induced locomotion and survival (Fig 5F and 5G). Together, these data indicate that nhr-86, but not nhr-203, is essential for E. faecium-mediated neuroprotection and functions upstream of CYP gene activation, while nhr-86 expression itself is not regulated by E. faecium, as shown by RNA-seq (S1 Table) and qRT-PCR (S13 Fig).

To further assess the role of NHR-86 in the transcriptional program activated by E. faecium, we compared the E. faecium–regulated transcriptome with the published NHR-86 ChIP-seq dataset [52]. This analysis revealed an overlap between E. faecium-induced genes and NHR-86-bound targets, including CYP genes such as cyp-35A1 and cyp-35A5, as well as numerous other genes (S1 Table). These findings indicate that NHR-86 acts as one of several transcriptional effectors mediating the host response to E. faecium.

To confirm that nhr-86 is required for this protective pathway (Fig 5B5G), we tested whether expression of nhr-86 under its endogenous promoter could rescue the reduced neuroprotection in sod-1 A4VM animals. These animals were generated by crossing nhr-86(tm2590);nhr-86p::nhr-86 animals with sod-1 A4VM animals (Fig 6A). Expression of NHR-86 fully restored E. faecium-mediated protection against cholinergic motor neuron degeneration in sod-1 A4VM animals (Fig 6B), and rescued the mRNA levels of cyp-35A1, cyp-35A3, and cyp-35A5 upon E. faecium exposure in sod-1 A4VM;nhr-86(tm2590) animals (Figs 6C and S14), and restored the protective effects of E. faecium on animal survival (Fig 6D6F) and locomotion (Fig 6G). These results indicate that the expression of nhr-86 under its own promoter is sufficient to reestablish CYP activation and confer neuroprotection in response to E. faecium. Notably, overexpression of NHR-86 alone did not confer neuroprotection or induce cyp expression on an E. coli diet (Fig 6B and 6C), indicating that NHR-86 activation depends on specific signals provided by E. faecium.

thumbnail

Fig 6. Native nhr-86 expression rescues sod-1 A4VM;nhr-86(tm2590) animals under oxidative stress.

(A) GFP fluorescence and corresponding brightfield images showing expression patterns of transgenes in different animals. Strain VL584 (nhr-86(tm2590);nhr-86p::nhr-86::gfp) expresses nhr-86p::GFP (arrows). Strain HA2631 (sod-1 A4VM) expresses unc-17p::GFP in cholinergic motor neurons. Strain AA260 co-expresses unc-17p::GFP and nhr-86p::GFP, highlighting both neuronal and intestinal expression domains. Scale bar: 200 μm. (B) Oxidative stress induced cholinergic motor neuron degeneration in sod-1 A4VM, sod-1 A4VM;nhr-86(tm2590), and sod-1 A4VM;nhr-86(tm2590);nhr-86p::nhr-86 animals treated with Enterococcus faecium or Escherichia coli for 24 hours before a 24-hour paraquat exposure. Cholinergic motor neuron integrity was assessed by scoring for the absence of at least two cholinergic motor neurons posterior to the vulva. * P < 0.05, ** P < 0.01, *** P < 0.001. (C) mRNA level of cyp-35A1 in sod-1 A4VM, sod-1 A4VM;nhr-86(tm2590), and sod-1 A4VM;nhr-86(tm2590);nhr-86p::nhr-86 animals. (N = 3 biological replicates). Values are expressed as the fold difference compared with worms fed on E. coli ± SD by one-way ANOVA with Tukey’s multiple comparisons test, * P < 0.05, ** P < 0.01, *** P < 0.001. (D) Survival curve of sod-1 A4VM animals with E. faecium or E. coli pretreatment, followed by paraquat-induced oxidative stress. (E) Survival curve of sod-1 A4VM;nhr-86(tm2590) animals with E. faecium or E. coli pretreatment, followed by paraquat-induced oxidative stress. (F) Survival curve of sod-1 A4VM;nhr-86(tm2590);nhr-86p::nhr-86::gfp animals with E. faecium and E. coli pretreatment, followed by paraquat-induced oxidative stress. (G) Locomotion analysis of sod-1 A4VM, sod-1 A4VM;nhr-86(tm2590), and sod-1 A4VM;nhr-86(tm2590);nhr-86p::nhr-86 animals following E. faecium pretreatment and paraquat exposure. The data underlying this Figure can be found in S1 Data.

https://doi.org/10.1371/journal.pbio.3003627.g006

The intestinal function of NHR-86 is required in E. faecium-mediated neuroprotection

NHR-86 is expressed in neurons, the intestine, and hypodermis [53]; however, because the CYP genes it regulates are primarily intestinal [54] and neurodegeneration occurs in neurons, we focused on its neuronal and intestinal roles.

To determine whether the neuronal NHR-86 function is required for neuroprotection during oxidative stress, we performed a neuron-specific knockdown of nhr-86 in sod-1 A4VM animals. We generated a neuron-specific RNAi ALS model by crossing sod-1 A4VM animals with the neuron-specific RNAi strain MAH677. Neuron-specific knockdown of nhr-86 had no effect on E. faecium-mediated neuroprotection (S15A and S15B Fig). dnc-1 served as a positive control, as its knockdown causes cholinergic motor neuron degeneration [55]. smn-1 was used as a negative control, as its neuron-specific RNAi affects only GABAergic motor neurons but does not impact cholinergic motor neurons [56]. Together, these results indicate that the neuronal function of NHR-86 is not required for the neuroprotective effect of E. faecium.

To determine whether the intestinal function of NHR-86 is required for neuroprotection during oxidative stress, we expressed NHR-86 specifically in the intestine of sod-1 A4VM animals (Fig 7A). For intestine-specific expression, nhr-86 was placed under the control of vha-6 promoter, which is active in intestinal cells [57]. Intestine-specific expression of NHR-86 fully restored E. faecium-mediated protection against motor neuron degeneration in sod-1 A4VM animals (Fig 7B), and rescued the mRNA levels of cyp-35A1, cyp-35A3, and cyp-35A5 in sod-1 A4VM;nhr-86(tm2590) animals (Figs 7C and S16). It also restored the protective effect of E. faecium on animal survival (Figs 6D, 6E, and 7D) and locomotion (Fig 7E). Together, these results indicate that the intestinal expression of NHR-86 is sufficient to reestablish CYP activation and confer neuroprotection upon exposure to E. faecium.

thumbnail

Fig 7. Intestinal nhr-86 expression rescues sod-1 A4VM;nhr-86(tm2590) animals under oxidative stress.

(A) Representative fluorescence micrographs of sod-1 A4VM;nhr-86(tm2590);nhr-86p::nhr-86::mCherry animals. n = 30; representative of four independent experiments. Scale bars indicate 200 µm. (B) Oxidative stress induced cholinergic motor neuron degeneration in sod-1 A4VM, sod-1 A4VM;nhr-86(tm2590), and sod-1 A4VM;nhr-86(tm2590);vha-6p::nhr-86 animals treated with Enterococcus faecium or Escherichia coli for 24 hours before a 24-hour paraquat exposure. (C) mRNA level of cyp-35A1 in sod-1 A4VM, sod-1 A4VM;nhr-86(tm2590), and sod-1 A4VM;nhr-86(tm2590);vha-6p::nhr-86 animals. (N = 3 biological replicates). Values are expressed as the fold difference compared with worms fed on E. coli ± SD by one-way ANOVA with Tukey’s multiple comparisons test, *** P < 0.001. (D) Survival curve of sod-1 A4VM;nhr-86(tm2590); vha-6p::nhr-86::gfp with E. faecium or E. coli pretreatment, followed by paraquat-induced oxidative stress. (E) Locomotion analysis of sod-1 A4VM, sod-1 A4VM;nhr-86(tm2590), and sod-1 A4VM;nhr-86(tm2590);vha-6p::nhr-86 animals following E. faecium pretreatment and paraquat exposure. The data underlying this Figure can be found in S1 Data.

https://doi.org/10.1371/journal.pbio.3003627.g007

Discussion

Our study demonstrates that probiotic E. faecium protects against oxidative stress-induced neurodegeneration in C. elegans (Fig 8), consistent with previous findings in mice showing antioxidant and neuromodulatory properties of E. faecium [58]. Rather than acting through classic immune pathways such as PMK-1/p38 MAPK [2830], DAF-16/FOXO [3133], ELT-2/GATA [34,35], and SKN-1/Nrf2 [36,37], which are down-regulated at the transcriptional level but are not required for protection in our RNAi assays, E. faecium-mediated neuroprotection depends on the transcription factor NHR-86. We show that NHR-86 is required for the transcriptional activation of a subset of CYP gene products that mitigate ROS and preserve neuronal function. Among the 284 NHRs encoded by the C. elegans genome [59,60], NHR-86 is the first linked to protection against neurodegeneration. Our work indicates that NHR-86 is a key regulator of probiotic-mediated stress resistance and reveals a functional NHR-CYP axis essential for preserving motor neuron integrity under oxidative conditions.

thumbnail

Fig 8. Model of Enterococcus faecium-mediated neuroprotection under oxidative stress.

The intestinal probiotic E. faecium protects motor neurons from degeneration during paraquat-induced oxidative stress by inducing cytochrome P450 (CYP). This induction requires the nuclear hormone receptor NHR-86. CYP enzymes detoxify reactive oxygen species (ROS) generated during oxidative stress, reducing ROS burden and protecting motor neurons. This model highlights an NHR-CYP regulatory axis through which gut microbial signals enhance neuronal resilience under environmental stress. Figure created using BioRender. Sang, Y. (2026) https://BioRender.com/fg7i4lx.

https://doi.org/10.1371/journal.pbio.3003627.g008

In addition to the NHR-86–CYP axis described here, several intestinal pathways in C. elegans have been implicated in neuronal protection, underscoring the importance of gut–neuron communication. For example, a mitochondria-regulated immune pathway in the intestine confers neuroprotection by coordinating stress responses across tissues [61]. Intestinal signaling through the rab-27 pathway regulates axon regeneration, highlighting a direct role for gut-derived signals in neuronal repair [62]. Additionally, metabolic intestine-to-neuron signaling, such as propionate supplementation, rescues α-synuclein-induced neurodegeneration [20], while gut-derived Wnt endocrine signaling regulates synaptic assembly in the nervous system [63]. Together, these findings establish that intestinal pathways—including mitochondrial stress responses, neurotransmitter signaling, metabolic circuits, and endocrine communication—contribute to neuronal resilience. Our identification of NHR-86 as a mediator of probiotic-induced neuroprotection places the NHR-86–CYP axis as a novel intestinal mechanism that complements previously described gut-driven protective pathways.

Our results establish NHR-86 as a central mediator of E. faecium-induced neuroprotection, acting upstream of cytochrome P450 genes to regulate oxidative stress responses. This regulatory relationship mirrors the function of HNF4 in human hepatocytes, where it controls the expression of multiple CPYs [64]. Although HNF4 has not previously been linked to neurodegenerative disorders, our findings raise the possibility that similar NHR-CYP regulatory circuits may operate in humans and influence neuronal survival under oxidative stress. This provides guidance to explore more functions of the key factor HNF4 in humans.

In our model, the intestinal probiotic E. faecium protects motor neurons during oxidative stress induced by paraquat. Mechanistically, E. faecium induces the expression of CYP enzymes, and the intestinal function of the nuclear hormone receptor NHR-86 is required for CYP induction and neuroprotection. These CYPs reduce intracellular ROS generated by paraquat-induced oxidative stress. Because ROS are diffusible, lowering their ROS levels in the intestine also reduces oxidative stress in neighboring motor neurons. Thus, the probiotic indirectly protects neurons by enhancing intestinal antioxidant capacity. These findings provide direct experimental evidence that intestinal responses to microbial signals can modulate neuronal resilience under environmental oxidative stress.

E. faecium-mediated neuroprotection is observed only in mutants with heightened stress sensitivity, such as sod-1 A4VM, but not in sod-1 WTM animals, where baseline stress is insufficient to induce degeneration. These findings indicate that ALS-linked SOD-1 mutations prime neurons for stress-induced degeneration, providing a context in which probiotics can exert measurable protective effects and highlighting the relevance of the sod-1 A4VM model for studying ALS-related neurodegeneration. While we focused on sod-1 A4VM-mediated motor neuron degeneration, our results in the sod-1 G85RM model indicate that E. faecium can also protect glutamatergic neurons, suggesting that its neuroprotective effects may extend to other ALS-associated mutations; future studies could explore its impact in additional ALS or Frontotemporal Dementia models.

Our data also strengthen the case for CYP enzymes as core effectors of cellular defense against oxidative stress. In diverse species, CYPs contribute to detoxification by metabolizing xenobiotics and reactive metabolic intermediates. In Daphnia magna, CYP360A8 mitigates paraquat-induced toxicity [65], and in C. elegans, CYP-35A2 and CYP-35B1 function in xenobiotic detoxification and stress adaptation [66]. Several mammalian CYPs also promote neuronal survival by eliminating toxic byproducts of cellular metabolism [67]. Beyond detoxification, CYPs metabolize polyunsaturated fatty acids into epoxyeicosatrienoic acids, which activate protective pathways that buffer free radicals and prevent subcellular damage [43]. Additionally, CYP152 enzymes act as peroxygenases that utilize hydrogen peroxide to catalyze fatty acid oxidation, facilitating efficient metabolism while maintaining cellular redox balance and mitigating oxidative stress [68]. Our identification of cyp genes as essential mediators of E. faecium-induced neuroprotection underscores their functional relevance in stress resilience.

These findings add to the growing body of evidence linking gut microbial signals to neuronal health. The gut–brain axis, increasingly recognized as a key modulator of neurodegenerative disease, is influenced by microbiota-derived metabolites that shape central nervous system function [69]. Microbial-derived short-chain fatty acids, generated during bacterial fermentation, possess neuroprotective properties and impact neuronal health and behavioral responsiveness [70]. Additionally, tryptophan from gut microbiota is essential for serotonin production, and disruptions in neurotransmitter balance can lead to mood disorders, cognitive decline, and neurodegeneration [71,72]. Our studies indicate that E. faecium is an intestinal probiotic capable of triggering a host transcriptional response with systemic protective outcomes. By activating NHR-86 in the intestine and inducing CYP expression, E. faecium promotes resistance to oxidative stress in motor neurons without engaging classical immune pathways, distinguishing this mechanism from those described for other lactic acid bacteria.

Together, our study defines a gut-driven, transcription factor-dependent mechanism by which a probiotic bacterium protects neurons from oxidative stress-induced degeneration. This work provides new insight into how microbial interactions at the intestinal interface can regulate host gene expression to prevent neurodegeneration. While further studies are needed to assess the relevance of this mechanism in higher organisms, our findings highlight a conserved transcriptional program that may be useful to mitigate neurodegeneration.

Materials and methods

Bacterial strains

The following bacterial strains were used: Escherichia coli OP50, E. coli HT115(DE3), Enterococcus faecium NCTC 7171. E. faecium was grown in brain–heart infusion (BHI) medium at 37 °C, and the cultures of other bacteria were grown in Luria-Bertani (LB) broth at 37 °C.

C. elegans strains

All C. elegans strains were maintained on nematode growth medium (NGM) and fed E. coli strain OP50. The C. elegans strains wild-type N2 Bristol, nhr-62(gk478), nhr-86(tm2590), nhr-130(gk710), nhr-235(gk1085), nhr-178(gk1005), nhr-178(gk1158), nhr-201(gk1231), nhr-203(gk660), nhr-207(gk632) and nhr-86(tm2590);nhr-86p::nhr-86(ORF)::GFP used were obtained from the Caenorhabditis Genetics Center (University of Minnesota, Minneapolis, MN). nhr-142(gk826), nhr-237(gk1050), nhr-11(tm1679), nhr-12(tm1038), nhr-106(tm1663), nhr-176(tm954), nhr-196(tm1042), and nhr-205(tm1185) animals were obtained from National Bioresource Project (NBRP), Japan.HA2630 sod-1 WTM and HA2631 sod-1 A4VM strain were gifts from Dr. Anne Hart [22]. Detailed strain information is listed in S3 Table.

Probiotic E. faecium pretreatment and paraquat exposure

Synchronized young adult animals were washed three times in M9 buffer and transferred to E. faecium lawns grown on 2% agar BHI plates for colonization for 1 day at 25 °C. The worms were then washed and transferred to paraquat agar plates containing OP50 lawn. A 250 mM stock solution of paraquat (Sigma-Aldrich 856177) was prepared in water and added to NGM media to achieve the 5 mM paraquat concentration. E. coli OP50 lawns were used as pretreatment control.

Fluorescent microscopy and cholinergic motor neurons integrity assessment

To assess the integrity of cholinergic motor neurons in C. elegans following paraquat exposure, we exposed HA2630 or HA2631 animals expressing unc-17p::GFP to 5 mM paraquat according to the specified protocol. After 24 hours, the animals were washed three times with M9 buffer, immobilized using 30 mM sodium azide (Sigma) in M9 buffer, mounted on a 2% agarose pad, and visualized using a Leica M165 FC fluorescence stereomicroscope. Defective cholinergic motor neurons were identified by scoring for the absence of at least two cholinergic motor neurons posterior to the vulva. All image acquisition and manual scoring were performed with researchers blinded to genotype and treatment.

Survival assay

Following 24 hours of paraquat exposure, the survival of sod-1 A4VM animals pretreated on E. faecium or E. coli lawns was recorded. Time point 0 was defined as the completion of the 24-hour paraquat treatment. Animals were transferred to new paraquat plates daily until all animals stopped laying eggs, and survival was scored.

Locomotion phenotype analysis

An image-based assay was used to assess the locomotion speed of C. elegans. Animals were transferred to a plate with a fresh bacterial lawn to trace movement tracks. Upon release, worms exhibited a maximum movement response for a short duration. A 15-s movie was recorded for each worm, and a picture was taken at the 15th second. The ratio of movement distance to body length, measured using NIH ImageJ software, was used as a movement index [73]. Measurements were taken 48 hours after transferring to 5 mM paraquat.

Glutamatergic neuron degeneration

Day 1 adult animals, pretreated with E. faecium and subsequently exposed to paraquat, were washed off the plates with M9 buffer and incubated with DiD (Fisher DiIC18(5), D307) in a microcentrifuge tube. After 1 hour, animals were transferred to a regular NGM plate. After another hour, animals were immobilized with 20 mM sodium azide in M9 buffer, mounted on a 2% agar pad, and covered with a glass coverslip. Fluorescent neuronal cell bodies were visualized and scored for lack of dye uptake under a Leica M165 FC fluorescence microscope.

RNA interference

RNA interference (RNAi) was used to generate loss-of-function phenotypes by feeding nematodes with E. coli strain HT115(DE3) expressing double-stranded RNA homologous to a target gene [74,75]. E. coli with the appropriate vectors were grown overnight at 37 °C in LB broth containing ampicillin (100 mg/mL) and tetracycline (12.5 mg/mL), then plated onto NGM plates containing 100 mg/mL ampicillin and 3 mM isopropyl β-D-thiogalactoside (IPTG) (RNAi plates). RNAi-expressing bacteria were allowed to grow overnight at 37 °C. Gravid adults were transferred to RNAi-expressing bacterial lawns and allowed to lay eggs for 2 hours. The gravid adults were then removed, and the eggs were allowed to develop at 20 °C in young adults for subsequent assays. First-generation RNAi was performed from eggs to young adults for all genes, except for elt-2 RNAi, which was conducted after animals reached the L4 stage on nematode growth medium.unc-22 RNAi was included as a positive control to account for RNAi efficiency. All RNAi clones were from the Ahringer RNAi library. Note: Neuronal RNAi is inefficient by feeding; the results here indicate that classic immune pathways in non-neuronal tissues are not required for E. faecium-mediated neuroprotection.

RNA sequencing and analysis

Approximately 100 gravid animals were placed on 10-cm NGM plates seeded with E. coli OP50 for 3 hours to obtain a synchronized population, which developed to the young adult stage at 20 °C. The synchronized young adult worms were washed three times in M9 buffer and transferred to E. faecium lawns grown on 2% agar BHI plates for colonization for 24 hours at 25 °C. The animals were then washed off the plates with M9, frozen in QIAzol using ethanol/dry ice, and stored at −80 °C prior to RNA extraction. Total RNA was extracted using the RNeasy Plus Universal Kit (Qiagen, the Netherlands), and residual genomic DNA was removed using TURBO DNase (Life Technologies, Carlsbad, CA). A total of 6 μg of RNA was reverse-transcribed with random primers using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA).

Library construction and RNA sequencing on the BGISEQ-500 platform were performed according to established protocols, and paired-end reads of 100 bp were obtained for subsequent data analysis. The RNA sequence data were analyzed using a workflow constructed for Galaxy (https://usegalaxy.org). The RNA reads were aligned to the C. elegans genome (WS230) using the aligner STAR. Counts were normalized for sequencing depth and RNA composition across all samples. Differential gene expression analysis was performed using normalized samples, and genes exhibiting at least a 2-fold change were considered differentially expressed. The differentially expressed genes were subjected to SimpleMine tools from WormBase to obtain information such as WormBase IDs and gene names for further analyses. GO analysis was performed using the WormBase IDs in the DAVID Bioinformatics Database and a C. elegans data enrichment analysis tool.

RNA isolation and quantitative reverse transcription PCR (qRT-PCR)

Animals were synchronized, and total RNA was extracted as described. qRT-PCR was performed using the Applied Biosystems One-Step Real-Time PCR protocol with SYBR Green fluorescence on an Applied Biosystems 7900HT machine. Reactions were analyzed per the manufacturer’s instructions. Relative fold changes were calculated using the comparative CT (2−ΔΔCT) method and normalized to pan-actin (act-1, -3, -4). Cycle thresholds were determined using StepOnePlus Real-Time PCR System Software v2.3. All results are based on three independent experiments, each performed in triplicate, with primer sequences listed in S4 Table.

Measurement of reactive oxygen species (ROS) in C. elegans

Worms were pretreated with E. faecium and exposed to paraquat, then subjected to ROS assays. ROS formation was measured using the fluorescent probes 2′,7′-dichlorofluorescein diacetate (H2DCFDA) (Sigma-Aldrich D6883). Animals with 24 hours E. faecium pretreatment and 24 hours of paraquat treatment were collected into 1 mL PBS, washed three times, and incubated with 50 μM H2DCFDA for 60 min at room temperature. Controls were incubated with DMSO. After washing three times with PBS, animals were immobilized using 30 mM sodium azide (Sigma) in M9 buffer, mounted on a 2% agarose pad, and visualized using a Leica M165 FC fluorescence stereomicroscope. DCF fluorescence intensity was measured at excitation/emission wavelengths of 488/510–560 nm using laser scanning confocal microscopy. The assay was performed in three independent trials with at least 25 animals per assay.

COPAS biosorter GFP analysis

DCF fluorescence intensity was analyzed using the COPAS Biosort flow cytometer (Union Biometrica). Worms pretreated with E. faecium and exposed to paraquat were washed three times and incubated with 50 μM H2DCF-DA before analysis. Fluorescence levels were measured using a 405-nm excitation laser and a 405-nm band-pass excitation filter with a neutral density of 0.6. The emission data were collected using a 512/25-nm band-pass emission filter (green channel). The acquired data were exported into Excel files and analyzed using Prism 9 (GraphPad).

Intestinal rescue of NHR-86

The vha-6 promoter and nhr-86 coding regions were PCR-amplified separately from Bristol N2 C. elegans genomic DNA using the primers listed in S4 Table. The two fragments were fused by overlapping PCR to generate the vha-6p::nhr-86 sequence. This sequence and the backbone plasmid pMS04 (Addgene #168172) were digested with the Kpn I and BgI II restriction enzymes. The fused vha-6p::nhr-86 fragment was then ligated into plasmid pMS04 between the Kpn I and BgI II sites to create the expression construct pMS04_vha-6p::nhr-86::mCherry. The final plasmid was purified and verified by sequencing. Young adult hermaphrodite sod-1(tm776) II; unc-119(+) III; rtSi008 [sod-1p::sod-1A4V M::sod-1 3’UTR + Cbr-unc-119(+)] IV; vsIs48 [unc-17p::GFP]; nhr-86(tm2590) animals were transformed by microinjection of plasmids into the gonads. A mixture containing the pMS04_vha-6p::nhr-86::mCherry plasmids (25 ng/µL) and pRF4_ rol-6(su1006) (25 ng/µL) as a transformation marker was injected into the worm. Successful transformation was determined by the identification of the selection marker as a dominant roller. At least three independent lines carrying extrachromosomal arrays were obtained for each construct.

Statistical analysis

Data were analyzed using a two-tailed Student t test for independent samples. For comparisons involving more than two groups, one-way ANOVA followed by post hoc analysis was employed. All experiments were conducted at least three times, with error bars representing the standard deviation unless otherwise noted. Statistical significance was defined as P < 0.05. The number of animals per experiment is denoted by “n”. “NS” indicates non-significant results, while asterisks denote significance levels: * P < 0.05, ** P < 0.01, *** P < 0.001. Survival fractions were calculated using the Kaplan–Meier method, and differences between survival curves were assessed with the log-rank test (S5 Table).

Supporting information

S1 Fig. Motor neuron degeneration under paraquat-induced oxidative stress.

Representative images show animals lacking (A) zero, (B) one, (C) two, and (D) more than 2 motor neurons posterior to the vulva. Animals missing at least two neurons were scored as defective. Missing neurons are marked with red circles.

https://doi.org/10.1371/journal.pbio.3003627.s001

(PDF)

S2 Fig. Motor neuron degeneration with or without Enterococcus faecium pretreatment.

Motor neuron degeneration in sod-1 WTM and in sod-1 A4VM animals was assessed under paraquat-induced oxidative stress, with or without E. faecium pretreatment. Animals missing at least two neurons were scored as defective. A two-tailed Student t test was performed to compare data between different treatments within the same group.

https://doi.org/10.1371/journal.pbio.3003627.s002

(PDF)

S3 Fig. Live Enterococcus faecium is required for neuroprotection.

(A) sod-1 A4VM animals were pretreated for 24 hours with live, UV-killed, or heat-killed E. faecium before exposure to paraquat-induced oxidative stress. Cholinergic motor neuron integrity was assessed. Data are represented as mean ± SD from three independent experiments. Statistical significance was determined using one-way ANOVA with Tukey’s multiple comparison test (***p < 0.001). (B) Summary of motor neuron defects from (A) across three independent experiments.

https://doi.org/10.1371/journal.pbio.3003627.s003

(PDF)

S4 Fig. Oxidative stress-induced glutamatergic neuron degeneration in sod-1 G85RC animals.

(A) Representative images of sod-1 G85RC animals showing intact glutamatergic sensory neurons in the tail labeled with DiD. After paraquat treatment, PHA and PHB neurons fail to take up the dye, indicating degeneration or neuronal loss. Scale bar represents 10 μm. (B) Percentage of defective PHA and PHB neurons in sod-1 G85RC ALS model animals after paraquat treatment. Results from three independent trials are shown. Error bars indicate ±SD. Statistical significance was determined using one-way ANOVA with Tukey’s multiple comparison test (***p < 0.001).

https://doi.org/10.1371/journal.pbio.3003627.s004

(PDF)

S6 Fig. Motor neuron degeneration under different RNAi knockdowns.

sod-1 A4VM animals were fed control, pmk-1, elt-2, daf-16, or skn-1 RNAi. Motor neuron degeneration was assessed under paraquat-induced oxidative stress, with or without Enterococcus faecium pretreatment. Animals missing at least two neurons were scored as defective. A two-tailed Student t test was performed to compare data between different treatments within the same group.

https://doi.org/10.1371/journal.pbio.3003627.s006

(PDF)

S7 Fig. mRNA levels of cytochrome P450 genes.

qRT-PCR validation of cyp genes that were up-regulated with Enterococcus faecium pretreatment (N = 3 biological replicates). Values are expressed as the fold difference compared with sod-1 WTM animals fed on Escherichia coli ± SD by one-way ANOVA with Tukey’s multiple comparison test.

https://doi.org/10.1371/journal.pbio.3003627.s007

(PDF)

S8 Fig. Motor neuron degeneration under cyp-35A12345 RNAi.

sod-1 A4VM animals were fed control or cyp-35A12345 RNAi. Motor neuron degeneration was assessed under paraquat-induced oxidative stress, with or without Enterococcus faecium pretreatment. Animals missing at least two neurons were scored as defective. One-way ANOVA was performed to compare the data. P values: Empty vector, Ec-paraquat versus Empty vector, Ef-paraquat, P < 0.0001; Empty vector, Ec-paraquat versus cyp-35A12345 RNAi, Ec-paraquat, P = 0.9997; Empty vector, Ef-paraquat versus cyp-35A12345 RNAi, Ef-paraquat, P < 0.0001; cyp-35A12345 RNAi, Ec-paraquat versus cyp-35A12345 RNAi, Ef-paraquat, P = 0.0022.

https://doi.org/10.1371/journal.pbio.3003627.s008

(PDF)

S9 Fig. Screen of NHRs required for cyp activation by Enterococcus faecium.

(A) Screening of nhr genes using (A) cyp-35A3 and (B) cyp-35A5 as reporters. Young adult nhr mutant animals pretreated on E. faecium or Escherichia coli lawns were harvested for RNA extraction and qRT-PCR assay. (N = 3 biological replicates). Values represent fold differences relative to animals fed on E. coli, analyzed by one-way ANOVA with Tukey’s multiple comparisons test, * P < 0.05, ** P < 0.01, *** P < 0.001.

https://doi.org/10.1371/journal.pbio.3003627.s009

(PDF)

S10 Fig. Motor neuron degeneration under nhr-86 or nhr-203 RNAi.

sod-1 A4VM animals were fed control, nhr-86 or nhr-203 RNAi. Motor neuron degeneration was assessed under paraquat-induced oxidative stress, with or without Enterococcus faecium pretreatment. Animals missing at least two neurons were scored as defective. One-way ANOVA was performed to compare the mean of nhr-86 RNAi and nhr-203 RNAi with the mean of empty vector pretreated with E. faecium.

https://doi.org/10.1371/journal.pbio.3003627.s010

(PDF)

S11 Fig. Quantification of DCF fluorescence intensity.

Intracellular ROS analysis of sod-1 A4VM animals after cyp-35A12345 knockdown, following Enterococcus faecium pretreatment and paraquat exposure. n = 25. The “n” represents the number of animals in each experiment. N = 3 biological replicates.

https://doi.org/10.1371/journal.pbio.3003627.s011

(PDF)

S12 Fig. Intracellular ROS analysis of sod-1 A4VM animals.

(A) Dot-plot representation of green fluorescence intensity versus TOF of empty vector and nhr-203 RNAi animals exposed to Enterococcus faecium or Escherichia coli followed by paraquat exposure (n = 300). (E) Frequency distribution of green fluorescence in vector or nhr-203 RNAi animals exposed to E. faecium or E. coli followed by paraquat exposure. Three independent experiments were conducted. Empty vector, Ec-paraquat versus Empty vector, Ef-paraquat, P = NS; nhr-203 RNAi, Ec-paraquat versus nhr-203 RNAi, Ef-paraquat, P = NS.

https://doi.org/10.1371/journal.pbio.3003627.s012

(PDF)

S13 Fig. mRNA levels of nhr-86.

qRT-PCR test nhr-86 expression Enterococcus faecium pretreatment (N = 3 biological replicates). Values are expressed as the fold difference compared with sod-1 WTM animals fed on Escherichia coli ± SD by one-way ANOVA with Tukey’s multiple.

https://doi.org/10.1371/journal.pbio.3003627.s013

(PDF)

S14 Fig. mRNA levels of cyp genes with nhr-86 rescue.

mRNA level of (A) cyp-35A3 and (B) cyp-35A5 in sod-1 A4VM, sod-1 A4VM;nhr-86(tm2590), and sod-1 A4VM;nhr-86(tm2590);nhr-86p::nhr-86 animals. (N = 3 biological replicates). Values are expressed as the fold difference compared with sod-1 A4VM animals treated by Escherichia coli ± SD by one-way ANOVA with Tukey’s multiple comparisons test, * P < 0.05, ** P < 0.01, *** P < 0.001.

https://doi.org/10.1371/journal.pbio.3003627.s014

(PDF)

S15 Fig. Motor neuron degeneration under different RNAi knockdowns.

(A) Oxidative stress induced cholinergic motor neuron degeneration in sod-1 A4VM animals. sod-1 A4VM;sid-1(qt9); rgef-1p::GFP;rgef-1p::sid-1 animals (AA258) were fed control, nhr-86, dnc-1, or smn-1 RNAi. After growing to young adults on RNAi plates, the animals were treated with Enterococcus faecium or Escherichia coli for 24 hours before a 24-hour paraquat exposure. Cholinergic motor neuron integrity was accessed by scoring for the absence of at least two cholinergic motor neurons posterior to the vulva. * P < 0.05, ** P < 0.01, *** P < 0.001, two-way ANOVA. (B) Summary of motor neuron defects from (A) across three independent experiments.

https://doi.org/10.1371/journal.pbio.3003627.s015

(PDF)

S16 Fig. mRNA levels of cyp genes with nhr-86 rescue in intestine.

mRNA level of (A) cyp-35A3 and (B) cyp-35A5 in sod-1 A4VM, sod-1 A4VM;nhr-86(tm2590), and sod-1 A4VM;nhr-86(tm2590);vha-6p::nhr-86 animals. (N = 3 biological replicates). Values are expressed as the fold difference compared with sod-1 A4VM animals treated by Escherichia. coli ± SD by one-way ANOVA with Tukey’s multiple comparisons test, * P < 0.05, ** P < 0.01, *** P < 0.001.

https://doi.org/10.1371/journal.pbio.3003627.s016

(PDF)

Acknowledgments

Most strains used in this study were obtained from the Caenorhabditis Genetics Center (CGC), which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440) and the National BioResource Project (NBRP) of Japan.

References

  1. 1. Hu Y, Petruzzello SJ, Hernandez ME. Beta cortical oscillatory activities and their relationship to postural control in a standing balance demanding test: influence of aging. Front Aging Neurosci. 2023;15:1126002. pmid:37213543
  2. 2. Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257–68. pmid:21944779
  3. 3. Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;364(6435):362. pmid:8332197
  4. 4. Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9(11):617–28. pmid:24126629
  5. 5. Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, et al. Trial of antisense oligonucleotide tofersen for SOD1 ALS. N Engl J Med. 2022;387(12):1099–110. pmid:36129998
  6. 6. Saeed M, Yang Y, Deng H-X, Hung W-Y, Siddique N, Dellefave L, et al. Age and founder effect of SOD1 A4V mutation causing ALS. Neurology. 2009;72(19):1634–9. pmid:19176896
  7. 7. Caldero-Escudero E, Romero-Sanz S, De la Fuente S. Using C. elegans as a model for neurodegenerative diseases: methodology and evaluation. Methods Cell Biol. 2024;188:1–34. pmid:38880519
  8. 8. Zhu L, Li S, Li X-J, Yin P. Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges. Transl Neurodegener. 2023;12(1):46. pmid:37730668
  9. 9. Shah AB, Baiseitova A, Zahoor M, Ahmad I, Ikram M, Bakhsh A, et al. Probiotic significance of Lactobacillus strains: a comprehensive review on health impacts, research gaps, and future prospects. Gut Microbes. 2024;16(1):2431643. pmid:39582101
  10. 10. La Fata G, Weber P, Mohajeri MH. Probiotics and the gut immune system: indirect regulation. Probiotics Antimicrob Proteins. 2018;10(1):11–21. pmid:28861741
  11. 11. Nakagawa H, Shiozaki T, Kobatake E, Hosoya T, Moriya T, Sakai F, et al. Effects and mechanisms of prolongevity induced by Lactobacillus gasseri SBT2055 in Caenorhabditis elegans. Aging Cell. 2016;15(2):227–36. pmid:26710940
  12. 12. Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cell Mol Life Sci. 2017;74(20):3769–87. pmid:28643167
  13. 13. Ghazisaeedi F, Meens J, Hansche B, Maurischat S, Schwerk P, Goethe R, et al. A virulence factor as a therapeutic: the probiotic Enterococcus faecium SF68 arginine deiminase inhibits innate immune signaling pathways. Gut Microbes. 2022;14(1):2106105. pmid:35921516
  14. 14. Im EJ, Lee HH-Y, Kim M, Kim M-K. Evaluation of enterococcal probiotic usage and review of potential health benefits, safety, and risk of antibiotic-resistant strain emergence. Antibiotics (Basel). 2023;12(8):1327. pmid:37627747
  15. 15. Sang Y, Ren J, Aballay A. The transcription factor HLH-26 controls probiotic-mediated protection against intestinal infection through up-regulation of the Wnt/BAR-1 pathway. PLoS Biol. 2022;20(3):e3001581. pmid:35263319
  16. 16. Alavi MS, Karimi G, Ghanimi HA, Roohbakhsh A. The potential of CYP46A1 as a novel therapeutic target for neurological disorders: an updated review of mechanisms. Eur J Pharmacol. 2023;949:175726. pmid:37062503
  17. 17. Kuban W, Daniel WA. Cytochrome P450 expression and regulation in the brain. Drug Metab Rev. 2021;53(1):1–29. pmid:33356626
  18. 18. Kaut O, Schmitt I, Wüllner U. Genome-scale methylation analysis of Parkinson’s disease patients’ brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1. Neurogenetics. 2012;13(1):87–91. pmid:22238121
  19. 19. Ur Rasheed MS, Mishra AK, Singh MP. Cytochrome P450 2D6 and Parkinson’s disease: polymorphism, metabolic role, risk and protection. Neurochem Res. 2017;42(12):3353–61. pmid:28871472
  20. 20. Wang C, Yang M, Liu D, Zheng C. Metabolic rescue of alpha-synuclein-induced neurodegeneration through propionate supplementation and intestine-neuron signaling in C. elegans. Cell Rep. 2024;43(3):113865.
  21. 21. Goh GYS, Winter JJ, Bhanshali F, Doering KRS, Lai R, Lee K, et al. NHR-49/HNF4 integrates regulation of fatty acid metabolism with a protective transcriptional response to oxidative stress and fasting. Aging Cell. 2018;17(3):e12743. pmid:29508513
  22. 22. Baskoylu SN, Yersak J, O’Hern P, Grosser S, Simon J, Kim S, et al. Single copy/knock-in models of ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration. PLoS Genet. 2018;14(10):e1007682. pmid:30296255
  23. 23. McCarthy S, Somayajulu M, Sikorska M, Borowy-Borowski H, Pandey S. Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10. Toxicol Appl Pharmacol. 2004;201(1):21–31. pmid:15519605
  24. 24. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4(5):P3. pmid:12734009
  25. 25. Angeles-Albores D, N Lee RY, Chan J, Sternberg PW. Tissue enrichment analysis for C. elegans genomics. BMC Bioinformatics. 2016;17(1):366. pmid:27618863
  26. 26. Angeles-Albores D, Lee R, Chan J, Sternberg P. Two new functions in the wormbase enrichment suite. MicroPubl Biol. 2018;2018:10.17912/W25Q2N. pmid:32550381
  27. 27. Yuen GJ, Ausubel FM. Both live and dead Enterococci activate Caenorhabditis elegans host defense via immune and stress pathways. Virulence. 2018;9(1):683–99. pmid:29436902
  28. 28. Troemel ER, Chu SW, Reinke V, Lee SS, Ausubel FM, Kim DH. p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet. 2006;2(11):e183. pmid:17096597
  29. 29. Kim DH, Feinbaum R, Alloing G, Emerson FE, Garsin DA, Inoue H, et al. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science. 2002;297(5581):623–6. pmid:12142542
  30. 30. Aballay A, Drenkard E, Hilbun LR, Ausubel FM. Caenorhabditis elegans innate immune response triggered by Salmonella enterica requires intact LPS and is mediated by a MAPK signaling pathway. Curr Biol. 2003;13(1):47–52. pmid:12526744
  31. 31. Garsin DA, Villanueva JM, Begun J, Kim DH, Sifri CD, Calderwood SB, et al. Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science. 2003;300(5627):1921. pmid:12817143
  32. 32. Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, et al. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature. 2003;424(6946):277–83. pmid:12845331
  33. 33. Singh V, Aballay A. Heat-shock transcription factor (HSF)-1 pathway required for Caenorhabditis elegans immunity. Proc Natl Acad Sci U S A. 2006;103(35):13092–7. pmid:16916933
  34. 34. Kerry S, TeKippe M, Gaddis NC, Aballay A. GATA transcription factor required for immunity to bacterial and fungal pathogens. PLoS One. 2006;1(1):e77. pmid:17183709
  35. 35. Shapira M, Hamlin BJ, Rong J, Chen K, Ronen M, Tan M-W. A conserved role for a GATA transcription factor in regulating epithelial innate immune responses. Proc Natl Acad Sci U S A. 2006;103(38):14086–91. pmid:16968778
  36. 36. Papp D, Csermely P, Sőti C. A role for SKN-1/Nrf in pathogen resistance and immunosenescence in Caenorhabditis elegans. PLoS Pathog. 2012;8(4):e1002673. pmid:22577361
  37. 37. Hoeven R van der, McCallum KC, Cruz MR, Garsin DA. Ce-Duox1/BLI-3 generated reactive oxygen species trigger protective SKN-1 activity via p38 MAPK signaling during infection in C. elegans. PLoS Pathog. 2011;7(12):e1002453. pmid:22216003
  38. 38. Navarro-Mabarak C, Camacho-Carranza R, Espinosa-Aguirre JJ. Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases. Drug Metab Rev. 2018;50(2):95–108. pmid:29451034
  39. 39. Veith A, Moorthy B. Role of cytochrome P450S in the generation and metabolism of reactive oxygen species. Curr Opin Toxicol. 2018;7:44–51. pmid:29527583
  40. 40. Hrycay EG, Bandiera SM. Involvement of cytochrome P450 in reactive oxygen species formation and cancer. Adv Pharmacol. 2015;74:35–84. pmid:26233903
  41. 41. Lingappan K, Jiang W, Wang L, Couroucli XI, Moorthy B. Sex-specific differences in hyperoxic lung injury in mice: role of cytochrome P450 (CYP)1A. Toxicology. 2015;331:14–23. pmid:25703676
  42. 42. Zhang W, Chen W, Li Z, Ma L, Yu J, Wang H, et al. Identification and characterization of three new cytochrome P450 genes and the use of RNA interference to evaluate their roles in antioxidant defense in Apis cerana cerana Fabricius. Front Physiol. 2018;9:1608. pmid:30498454
  43. 43. Sarparast M, Dattmore D, Alan J, Lee KSS. Cytochrome P450 metabolism of polyunsaturated fatty acids and neurodegeneration. Nutrients. 2020;12(11):3523. pmid:33207662
  44. 44. Menzel R, Rödel M, Kulas J, Steinberg CEW. CYP35: xenobiotically induced gene expression in the nematode Caenorhabditis elegans. Arch Biochem Biophys. 2005;438(1):93–102. pmid:15910738
  45. 45. Yoon DS, Lee M-H, Cha DS. Measurement of intracellular ROS in Caenorhabditis elegans using 2’,7’-dichlorodihydrofluorescein diacetate. Bio Protoc. 2018;8(6):e2774. pmid:29744374
  46. 46. Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Bäckman M, et al. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci U S A. 1998;95(21):12208–13. pmid:9770465
  47. 47. Wallace SW, Lizzappi MC, Magemizoglu E, Hur H, Liang Y, Shaham S. Nuclear hormone receptors promote gut and glia detoxifying enzyme induction and protect C. elegans from the mold P. brevicompactum. Cell Rep. 2021;37(13):110166 pmid:34965433
  48. 48. Honkakoski P, Negishi M. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J. 2000;347(Pt 2):321–37. pmid:10749660
  49. 49. Tolson AH, Wang H. Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv Drug Deliv Rev. 2010;62(13):1238–49. pmid:20727377
  50. 50. Wallace BD, Redinbo MR. Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective. Drug Metab Rev. 2013;45(1):79–100. pmid:23210723
  51. 51. Karengera A, Sterken MG, Kammenga JE, Riksen JAG, Dinkla IJT, Murk AJ. Differential expression of genes in C. elegans reveals transcriptional responses to indirect-acting xenobiotic compounds and insensitivity to 2,3,7,8-tetrachlorodibenzodioxin. Ecotoxicol Environ Saf. 2022;233:113344. pmid:35219257
  52. 52. Peterson ND, Cheesman HK, Liu P, Anderson SM, Foster KJ, Chhaya R, et al. The nuclear hormone receptor NHR-86 controls anti-pathogen responses in C. elegans. PLoS Genet. 2019;15(1):e1007935. pmid:30668573
  53. 53. Arda HE, Taubert S, MacNeil LT, Conine CC, Tsuda B, Van Gilst M, et al. Functional modularity of nuclear hormone receptors in a Caenorhabditis elegans metabolic gene regulatory network. Mol Syst Biol. 2010;6:367. pmid:20461074
  54. 54. Imanikia S, Hylands P, Stürzenbaum SR. The double mutation of cytochrome P450’s and fatty acid desaturases affect lipid regulation and longevity in C. elegans. Biochem Biophys Rep. 2015;2:172–8. pmid:29124160
  55. 55. Ikenaka K, Kawai K, Katsuno M, Huang Z, Jiang Y-M, Iguchi Y, et al. dnc-1/dynactin 1 knockdown disrupts transport of autophagosomes and induces motor neuron degeneration. PLoS One. 2013;8(2):e54511. pmid:23408943
  56. 56. Gallotta I, Mazzarella N, Donato A, Esposito A, Chaplin JC, Castro S, et al. Neuron-specific knock-down of SMN1 causes neuron degeneration and death through an apoptotic mechanism. Hum Mol Genet. 2016;25(12):2564–77. pmid:27260405
  57. 57. Allman E, Johnson D, Nehrke K. Loss of the apical V-ATPase a-subunit VHA-6 prevents acidification of the intestinal lumen during a rhythmic behavior in C. elegans. Am J Physiol Cell Physiol. 2009;297(5):C1071-81. pmid:19741196
  58. 58. Divyashri G, Krishna G, Muralidhara, Prapulla SG. Probiotic attributes, antioxidant, anti-inflammatory and neuromodulatory effects of Enterococcus faecium CFR 3003: in vitro and in vivo evidence. J Med Microbiol. 2015;64(12):1527–40. pmid:26450608
  59. 59. Gissendanner CR, Crossgrove K, Kraus KA, Maina CV, Sluder AE. Expression and function of conserved nuclear receptor genes in Caenorhabditis elegans. Dev Biol. 2004;266(2):399–416. pmid:14738886
  60. 60. Robinson-Rechavi M, Carpentier AS, Duffraisse M, Laudet V. How many nuclear hormone receptors are there in the human genome? Trends Genet. 2001;17(10):554–6. pmid:11585645
  61. 61. Chikka MR, Anbalagan C, Dvorak K, Dombeck K, Prahlad V. The mitochondria-regulated immune pathway activated in the C. elegans intestine is neuroprotective. Cell Rep. 2016;16(9):2399–414. pmid:27545884
  62. 62. Derseh BT, Tafese NM, Panari H, Bilchut AH, Dadi AF. Behavioral and environmental determinants of acute diarrhea among under-five children from public health facilities of Siyadebirena Wayu district, north Shoa zone, Amhara regional state, Ethiopia: unmatched case-control study. PLoS One. 2021;16(11):e0259828. pmid:34807922
  63. 63. Shi Y, Qin L, Wu M, Zheng J, Xie T, Shao Z. Gut neuroendocrine signaling regulates synaptic assembly in C. elegans. EMBO Rep. 2022;23(8):e53267. pmid:35748387
  64. 64. Jover R, Bort R, Gómez-Lechón MJ, Castell JV. Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting. Hepatology. 2001;33(3):668–75. pmid:11230748
  65. 65. Religia P, Nguyen ND, Nong QD, Matsuura T, Kato Y, Watanabe H. Mutation of the cytochrome P450 CYP360A8 Gene increases sensitivity to Paraquat in Daphnia magna. Environ Toxicol Chem. 2021;40(5):1279–88. pmid:33338286
  66. 66. Abbass M, Chen Y, Arlt VM, Stürzenbaum SR. Benzo[a]pyrene and Caenorhabditis elegans: defining the genotoxic potential in an organism lacking the classical CYP1A1 pathway. Arch Toxicol. 2021;95(3):1055–69. pmid:33420596
  67. 67. Martin MG, Trovò L, Perga S, Sadowska A, Rasola A, Chiara F, et al. Cyp46-mediated cholesterol loss promotes survival in stressed hippocampal neurons. Neurobiol Aging. 2011;32(5):933–43. pmid:19497639
  68. 68. Munro AW, McLean KJ, Grant JL, Makris TM. Structure and function of the cytochrome P450 peroxygenase enzymes. Biochem Soc Trans. 2018;46(1):183–96. pmid:29432141
  69. 69. Chen Y, Xu J, Chen Y. Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders. Nutrients. 2021;13(6):2099. pmid:34205336
  70. 70. Loh JS, Mak WQ, Tan LKS, Ng CX, Chan HH, Yeow SH, et al. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther. 2024;9(1):37. pmid:38360862
  71. 71. Gao K, Mu C-L, Farzi A, Zhu W-Y. Tryptophan metabolism: a link between the gut microbiota and brain. Adv Nutr. 2020;11(3):709–23. pmid:31825083
  72. 72. Młynarska E, Jakubowska P, Frąk W, Gajewska A, Sornowska J, Skwira S, et al. Associations of microbiota and nutrition with cognitive impairment in diseases. Nutrients. 2024;16(20):3570. pmid:39458564
  73. 73. Wang J, Farr GW, Hall DH, Li F, Furtak K, Dreier L, et al. An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans. PLoS Genet. 2009;5(1):e1000350. pmid:19165329
  74. 74. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, Ahringer J. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature. 2000;408(6810):325–30. pmid:11099033
  75. 75. Timmons L, Fire A. Specific interference by ingested dsRNA. Nature. 1998;395(6705):854. pmid:9804418
Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway